Skip to main content
. 2022 May 9;19:550–568. doi: 10.1016/j.bioactmat.2022.04.029

Fig. 6.

Fig. 6

Assessment of formation of both fibrotic scar and glial scar. (a) PDGFR-β (platelet-derived growth factor receptor-β, fibrotic scar marker) and GFAP (glial fibrillary acidic protein, glial scar marker) double immunofluorescence staining of spinal cord tissues at the lesion sites. (b) quantitative analysis of scaring levels by (b1) PDGFR-β+-positive area and (b2) GFAP+-positive area. The dashed lines outline the 2 mm lesion sites.